Solid Tumor Chemotherapy and in Vivo Distribution of Fluorouracil Following Administration in Poly(L-Lactic Acid) Microspheres

References

• Mehta R. C., Jeyanthi R., Calis S., Thanoo B. C., Burton K. W., DeLuca P. K. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Control. Release 1994; 29: 375–384
   Web of Science ®Google Scholar
• Grubb G., Welch J., Cole L., Goldsmith A., Riveria R. A. Comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone microspheres for controlled release steroid contraception: Phase II study. Fertil. Steril 1989; 51: 803–811
   PubMed Web of Science ®Google Scholar
• Yolles S., Eldridge J., Leafe T. D., Woodland J. H., Blake D. R., Meyer F. J. Long-acting delivery systems for narcotic antagonists. Adv. Exp. Med. Biol 1973; 47: 177–183
   Google Scholar
• Wise D., McCormick G. F., Willet G. P., Anderson L. C. Sustained release of an antimalarial drug using a copolymer at glycolic/lactic acid. Life Sci 1976; 19: 867–872
   PubMed Web of Science ®Google Scholar
• Hecquet B., Chabot F., Delatone G., Fournier C., Hilati S., Cambies S. L., Depadt G., Vert M. In vivo sustained release of cisplatin from bioresorbable implants in mice. Anticancer Res 1986; 6: 1251–1261
   PubMed Web of Science ®Google Scholar
• Strobel J., Laughin T. J., Astray F., Lilly M. D., Perkins B. H., Dunn R. L. Controlled release systems for anticancer agents. Proc. Int. Symp. Control. Rel. Bioact. Mater 1980; 7: 129
   Google Scholar
• Sanders L. M., Kent J. S., McRae G. I., Vickery B. H., Tice T. R., Lewis D. H. Controlled release of an LHRH analogue from poly (dl-lactide-co-glycolide) microspheres. J. Pharm. Sci 1984; 73: 1294–1301
   PubMed Web of Science ®Google Scholar
• Parker W. B., Cheng Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharm. Ther 1990; 48: 381–395
   PubMed Web of Science ®Google Scholar
• Bruijin E. A., Oosteram A. T., Tjaden U. R. Site specific delivery of 5-fluorouracil with 5-deoxy-5-fluorouridine. Reg. Cancer Treat 1989; 2: 61–76
   Google Scholar
• Ciftci K., Kas H. S., Hincal A. A. In vitro and in vivo evaluation of PLAGA microspheres containing 5-FU prepared by a solvent evaporation method. Int. J. Pharm 1996; 131: 73–82
   Web of Science ®Google Scholar
• Ciftci K. Preparation and in vitro-in vivo evaluation of bio-degradable microspheres containing 5-fluorouracil. Ph.D. thesis, University of Hacettepe, Turkey 1993
   Google Scholar
• Ciftci K., Hincal A. A., Kas H. S., Ercan M., Ruacan S. Micro-spheres of 5-FU using poly(dl-lactic acid), In vitro release properties and distribution in mice after i.v. administration. Eur. J. Pharm 1994; 1: 249–258
   Google Scholar
• Aamdal S., Oystein F., Pihl A. Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response. Int. J. Cancer 1984; 34: 725–730
   PubMed Web of Science ®Google Scholar
• Bogden A., Cobb W., Lepage D. J., Haskel P. Chemotherapy responsiveness of human rumors as first transplant generation xenografts in the normal mouse. Cancer 1981; 48: 10–20
   PubMed Web of Science ®Google Scholar
• Fingert H. J., Chen Z., Mizrahi N., Gajewski W. H., Bamberg M. P., Kradin R. L. Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay. Cancer Res 1987; 47: 3824–3829
   PubMed Web of Science ®Google Scholar
• Krause J., Schwarz A., Rodhewald P. Polylactide acid nano-spheres, a colloidal drug delivery system for lipophilic drugs. Int. J. Pharm 1985; 27: 145–155
   Web of Science ®Google Scholar
• Basic Pathology, S. L. Robins, V. Kumar. W B. Saunders. 1987; 1–20
   Google Scholar
• Jalil R., Nixon J. R. Microencapsulation using poly(L-lactic acid). IV: Release properties of microcapsules containing pheno-barbitone. J. Microencapsulation 1990; 7: 53–66
   PubMed Web of Science ®Google Scholar
• Bamba M., Puisieux F., Marty J. P., Carstensen J. T. Release mechanism in gel forming sustained release preparations. Int. J. Pharm 1979; 2: 307–315
   Web of Science ®Google Scholar
• Bos R. R. M., Rozema F. R., Boering G., Leenslag J. W., Pennigs A. J., Verwey A. B. In vivo and in vitro degradation of poly(L-lactide) used for fracture fixation. Adv. Biomater 1988; 8: 245–250
   Google Scholar
• Izumikawa S., Yoshioka S., Aso Y., Takeda Y. Preparation of poly(L-lactide) microspheres different crystalline morphology and effect of crystalline morphology on drug release rate. J. Control. Rel 1991; 15: 133–140
   Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate release of solid drugs dispersed in solid matrix. J. Pharm. Sci 1963; 52: 1145–1149
   PubMed Web of Science ®Google Scholar
• Vidmar V., Smolcic-Bubalo A., Jalsenjack I. Poly(lactic acid) microencapsulated oxytetracycline: In vitro and in vivo evaluation. J. Microencapsulation 1984; 1: 131–136
   PubMedGoogle Scholar
• Tice T. R., Cowsar D. R. Biodegradable controlled release parentral systems. Pharm. Technol 1984; 8: 26–29
   Google Scholar
• Sheffel U., Rhodes B. A., Wagner H. N. Albumin microspheres for study of the reticuloendothelial system. J. Nucl. Med 1972; 13: 498–503
   PubMed Web of Science ®Google Scholar
• Hazrati A. M., Akrawi S., Hickey A. J., Wedlund J., Macdonald J., DeLuca P. P. Tissue distribution of indium-III labeled poly-(glycolic acid) matrices following jugular and hepatic portal vein administration. J. Control. Rel 1989; 9: 205–214
   Web of Science ®Google Scholar
• Lay A. M., Vert M., Gautier J. C., Benoit J. P. Fate of 14-C poly-(lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int. J. Pharm 1994; 106: 201–211
   Google Scholar
• Stolnik S., Dunn S. E., Garnett M. C., Davies M. C., et al. Surface modification of poly(lactide-co-glycolide) poly(lactide)-poly(ethylene-glycol) copolymers. Pharm. Res 1994; 11: 1800–1807
   PubMed Web of Science ®Google Scholar